期刊文献+

辛伐他汀对糖尿病大鼠MMP-9表达的影响及对肾脏保护的研究 被引量:4

Effects of simvastatin on the renal injury of diabetic rats and renal expression of matrix metalloproteinase-9
下载PDF
导出
摘要 目的观察辛伐他汀对糖尿病大鼠肾脏的保护作用及其对肾组织基质金属蛋白酶-9(MMP-9)mRNA表达和尿MMP-9排泄的影响。方法将Wistar大鼠随机分为正常对照组、糖尿病组、辛伐他汀治疗组。检测各组第8周血糖、HbA1c、12 h尿视黄醇结合蛋白(RBP)、尿白蛋白(al-bumin,ALB)和尿MMP-9排泄率,第8周留取肾脏标本做电镜观察及采用逆转录PCR(RT-PCR)检测MMP-9mRNA。结果①第8周,糖尿病组及辛伐他汀治疗组尿ALB、RBP、MMP-9排泄率均高于正常对照组(P<0.01),辛伐他汀治疗组较糖尿病组有明显减少(P<0.01);尿MMP-9排泄率与尿ALB和RBP排泄率呈正相关关系。②第8周,与正常对照组相比,糖尿病组大鼠肾脏MMP-9mRNA表达明显上调(P<0.01),而辛伐他汀治疗组MMP-9mRNA表达则较糖尿病组明显下降(P<0.01)。电镜下辛伐他汀治疗组肾脏病理改变较糖尿病组明显减轻,同正常对照组相比仅有少量病变。结论辛伐他汀对糖尿病大鼠具有确切的肾脏保护作用,部分与其抑制肾脏MMP-9过度表达有关。 Objective To observe the effects of simvastatin on the expression of matrix metalloproteinase-9 (MMP-9) mRNA in renal tissue and urinary MMP-9 excretion of diabetic rats and find its renal protective mechanisms. Methods 24 Wistar rats were randomly divided into control, diabetic, simvastatin treament groups. Peripheral blood glucose, HbAlc, the urinary albumin ( ALB), retinal-binding protein (RBP) and MMP-9 were tested at 8th week. The renal tissue of rats were obtained for renal pathological changes by electron micro- scope and RT-PCR to examine the expression of MMP-9. Results (1)At the 8th week, the urine excretion rates of ALB, RBP and MMP-9 in diabetic and simvastatin treament groups were higher than those in control group (P 〈0.01 ). In simvastatin treament group, they were de- creased significantly than those in diabetic group (P 〈0.01 ). Urinary MMP-9 level was positive correlated with the urinary ALB and RBP levels. (2)The expression of MMP-9 mRNA was markedly up-regulated in diabetic group compared with that in control group, which in simvastatin treament group was much lower than that in diabetic group (P 〈 0. 01 ), the renal pathological changes in simvastatin treament group were much lighter than those of diabetic group, but a little heavier than those of control group. Conclusions Simvastatin has a renal-protection effect, which may be associated partly with down-regulated over-expression of renal tissue MMP-9.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第12期1472-1475,共4页 Chinese Journal of Gerontology
基金 安徽省教育厅自然科学研究资助项目(No.2006KJ318B) 安徽省自然科学基金资助项目(No.070413255X)
关键词 辛伐他汀 糖尿病 糖尿病肾病 基质金属蛋白酶-9 Simvastatin Diabetes mellitus Diabetic nephropathy Matrix metalloproteinase-9
  • 相关文献

参考文献11

  • 1Maki U, Shoji K, Takashi K, et al. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis [J]. Nephrol Dial Transplant,2002 ; 17 ( 7 ) : 1189-96.
  • 2郭清华,陆菊明,潘长玉,母义明,邹效漫.糖尿病肾病小鼠肾组织基质金属蛋白酶9的表达及其细胞内信号传导机制的探讨[J].中华糖尿病杂志(1006-6187),2005,13(2):137-139. 被引量:16
  • 3Vincent L, Chen W, Hong L, et al. Inhibition of endothelial cell migration by cerivastatin,an HMG-CoA reductase inhibitor:contribution to its anti- angiogenic effect[ J]. FEBS Lett,2001 ;495 ( 3 ) : 159-66.
  • 4Hitomi Usui, Kenichi Shikata, Mitsuhiro Matsuda, et al. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats [ J ]. Nephrol Dial Transplant,2003 ; 18 ( 7 ) : 265-72.
  • 5Ota T, Takamura T, Ando H,et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model[ J]. Diabetologia,2003 ;46 (6) :843-51.
  • 6Nogaki F, Muso E, Yashiro M, et al. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells [ J]. Kidney Int Suppl,1999 ;71 ( 1 ) :S198-201.
  • 7Economides PA, Caselli A, Tiani E, et al. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes [ J]. J Clin Endocrinol Metab,2004 ;89 (2) :740-7.
  • 8Kunieda Y, Nakagawa K, Nishimura H,et al. HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin Ⅱ in cultured rat aortic endothelial cells [ J ]. Thromb Res, 2003 ; 110 ( 4 ) : 227-34.
  • 9Lopez S, Peirctti F, Bonardo B, et al. Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesis in human monocytes/macrophages [ J ]. Cardiovasc Pharmacol,2001 ;37 (6) :762-8.
  • 10Wassmann S, Laufs U, Baumer AT, et al. Inhibition of geranylgeranylation reduces angiotensin Ⅱ-mediated free radical production in vascular smooth muscle cells : involvement of angiotensin AT1 receptor expression and Racl GTPase[J]. Mol Pharmacol,2001 ;59(3) :646-54.

二级参考文献8

  • 1Murphy G,Docherty AJP. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol,1992,7:120-125.
  • 2Iwatasuka H, Shimo A, Suzuoki Z. General survey of diabetic features of yellow KK mice. Endocrinol Jpn,1970,17:23-35.
  • 3Makita Z, Vlassara H, Cerami A, et al. Immunochemical detection of advanced glycosylation end products in vivo. J Biol Chem,1992,267:5133-5138.
  • 4Dignam JD,Lebovitz RM,Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res,1983,11:1475-1489.
  • 5Brownlee M. Advanced glycosylation in diabetes and aging. Annu Rev Med, 1995,46:223-234.
  • 6Wu K,Setty S,Mauer SM,et al. Altered kidney metrix gene expression in early stages of experimental diabetes. Acta Anat Basel,1997,158:155-165.
  • 7Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism. Cell,1986,47:921-928.
  • 8Sato H, Kita M, Seiki M. v-Src activates the expression of 92-kDa type IV collagesnase gene through the site and the AP-1 and the GT box homologous to retinoblastoma control elements:a mechanism regulating gene expression independent of that by inflammatory cytokines. J Biol Chem,1993,268:23460-23468.

共引文献15

同被引文献70

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部